Advanced Enzyme Technologies' Q3 FY 2025-26 Quarterly Results
- 01 Feb 2026
Result Summary
- Advanced Enzyme Technologies Ltd reported a 7.4% quarter-on-quarter (QoQ) decrease in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 2.0%.
- Its expenses for the quarter were down by 1.4% QoQ and up 7.8% YoY.
- The net profit decreased 3.5% QoQ and increased 11.1% YoY.
- The earnings per share (EPS) of Advanced Enzyme Technologies Ltd stood at 3.79 during Q3 FY 2025-26.
Financial Statments for Q3 FY 2025-26
Total Income | 180.42 | 194.81 | 176.80 | -7.4% | 2.0% |
Total Expenses | 133.38 | 135.27 | 123.77 | -1.4% | 7.8% |
Profit Before Tax | 58.29 | 59.54 | 53.02 | -2.1% | 9.9% |
Tax | 15.11 | 14.81 | 14.14 | 2.0% | 6.9% |
Profit After Tax | 43.18 | 44.74 | 38.88 | -3.5% | 11.1% |
Earnings Per Share | 3.79 | 3.87 | 3.36 | -2.1% | 12.8% |
Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results
Company Overview
Advanced Enzyme Technologies Ltd is primarily engaged in the research, development, manufacturing, and distribution of enzymes and probiotics. The company operates within the biotechnology industry, focusing on the application of enzymes in various sectors such as pharmaceuticals, food processing, animal nutrition, and more. Enzymes serve as catalysts in biochemical reactions, and the company has established itself as a key player in providing these solutions to enhance production efficiencies in diverse industries. There have been no significant recent developments publicly available about the company beyond its regular business operations.
Revenue
During the quarter ending Q3FY26, Advanced Enzyme Technologies Ltd reported a total income of ₹180.42 crores. This represents a decrease of 7.4% on a quarter-over-quarter basis compared to ₹194.81 crores in Q2FY26. However, when compared to the same quarter in the previous year, Q3FY25, where the total income was ₹176.80 crores, there is an increase of 2.0% year-over-year. This mixed performance in revenue indicates changes in quarterly sales performance over the periods in review, reflecting the company's operational dynamics and market conditions within the enzyme technology sector.
Profitability
The company's profitability metrics, as illustrated in the financial data, show that the profit before tax for Q3FY26 was ₹58.29 crores, slightly declining by 2.1% from ₹59.54 crores in Q2FY26. This represents a consistent year-over-year growth of 9.9% compared to ₹53.02 crores in Q3FY25. The profit after tax for Q3FY26 stood at ₹43.18 crores, reflecting a decrease of 3.5% from the previous quarter's ₹44.74 crores. Comparatively, there is an 11.1% increase from the ₹38.88 crores reported in Q3FY25. This indicates a steady annual growth trend despite the quarterly decline. The earnings per share (EPS) for Q3FY26 was ₹3.79, showing a decrease of 2.1% from Q2FY26's ₹3.87, yet marking a 12.8% increase from the EPS of ₹3.36 in Q3FY25.
Operating Metrics
Examining the operating metrics, the total expenses for Advanced Enzyme Technologies Ltd in Q3FY26 were ₹133.38 crores. This represents a slight decrease of 1.4% compared to the previous quarter, Q2FY26, where expenses were ₹135.27 crores. Year-over-year, there is an increase of 7.8% from the expenses of ₹123.77 crores in Q3FY25. The tax expense for Q3FY26 was ₹15.11 crores, which is a 2.0% increase from Q2FY26's ₹14.81 crores, and a 6.9% rise from ₹14.14 crores in Q3FY25. The trends in these operating metrics showcase the company's cost management strategies and fiscal discipline over the reviewed periods.